Division of Maternal and Fetal Medicine, Department of Obstetrics and Gynaecology, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada; University of Utah School of Medicine, Salt Lake City, UT.
Division of Maternal and Fetal Medicine, Department of Obstetrics and Gynaecology, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada; McMaster University, Hamilton, Ontario, Canada.
Am J Obstet Gynecol MFM. 2020 Aug;2(3):100116. doi: 10.1016/j.ajogmf.2020.100116. Epub 2020 Apr 16.
To evaluate reported outcomes of published studies on the diagnosis and management of vasa previa in pregnancy.
Databases such as MEDLINE, Embase, Cochrane, PubMed, and ClinicalTrials.gov were searched up to March 2018 for all published studies on vasa previa using combinations of the following medical subject headings and key words: vasa previa, placenta previa, low-lying placenta, succenturiate lobe or placenta, bilobed or bilobate placenta, and velamentous insertion. All original human research that described maternal, obstetric, placental, fetal or neonatal outcomes relating to pregnancies with vasa previa were included for analysis. Title and abstract screening and data extraction was conducted independently and in duplicate by 2 reviewers for all studies until total agreement for eligibility was achieved. Data extraction was also conducted in duplicate in approximately 50% of studies reviewed.
A total of 160 published studies (1004 pregnancies) were included. There was a wide range of reported outcomes, many of which were sparingly reported. The most commonly reported maternal outcomes included mode of delivery, presence of antepartum hemorrhage, time of diagnosis, and rupture of membranes. The presence of known risk factors for vasa previa such as a low-lying placenta, succenturiate or bilobed placenta, and (velamentous) cord insertion was incorrectly reported as "outcomes" in many studies. The most commonly reported fetal/neonatal outcomes included fetal heart rate, gestational age at delivery, birthweight, Apgar score, presence of neonatal anemia, cord blood gas measurements, need for blood transfusion, and death. Of note, only 3 studies reported outcomes related to life impact, maternal social and emotional functioning, perceived delivery of care, or resource utilization.
Despite the profound effect the diagnosis of vasa previa has on pregnant women, families, and healthcare systems, studies on vasa previa seldom report outcomes related to life impact and resource utilization. There is a need for the development of a core outcome set-a minimum standard set of outcomes deemed important by pregnant women and other stakeholders involved in their care-to standardize outcome reporting in future studies on vasa previa.
评估已发表的关于妊娠期间前置血管诊断和处理的研究报告结果。
截至 2018 年 3 月,通过 MEDLINE、Embase、Cochrane、PubMed 和 ClinicalTrials.gov 等数据库,使用以下医学主题词和关键词的组合,搜索所有关于前置血管的已发表研究:前置血管、前置胎盘、低位胎盘、副胎盘叶或胎盘、双叶或双瓣胎盘和帆状附着。所有描述与前置血管相关的母亲、产科、胎盘、胎儿或新生儿结局的原始人类研究均被纳入分析。所有研究的标题和摘要筛选以及数据提取均由 2 名评审员独立进行,直到对纳入标准达成完全一致。在大约 50%的已审查研究中,还进行了重复的数据提取。
共纳入 160 篇已发表的研究(1004 例妊娠)。报告的结果范围广泛,其中许多结果报告得很少。最常报告的产妇结局包括分娩方式、产前出血的存在、诊断时间和胎膜破裂。许多研究错误地将前置血管的已知危险因素(如低位胎盘、副胎盘或双叶胎盘和(帆状)脐带附着)的存在报告为“结局”。最常报告的胎儿/新生儿结局包括胎心率、分娩时的胎龄、出生体重、阿普加评分、新生儿贫血的存在、脐血血气测量、输血的需要以及死亡。值得注意的是,只有 3 项研究报告了与生活影响、产妇社会和情感功能、护理提供的感知或资源利用相关的结局。
尽管前置血管的诊断对孕妇、家庭和医疗保健系统有深远的影响,但关于前置血管的研究很少报告与生活影响和资源利用相关的结局。需要制定一个核心结局集——一组由参与孕妇及其护理的孕妇和其他利益相关者认为重要的最小标准结局,以规范未来关于前置血管的研究报告结局。